===
EQS-News: Alzchem Group AG / Key word(s): AGM/EGM
Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per
share approved
2024-05-07 / 16:21 CET/CEST
The issuer is solely responsible for the content of this announcement.
Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per
share approved
Trostberg, May 7, 2024 - At today's virtual Annual General Meeting, the Management Board and Supervisory Board once
again received strong approval from the shareholders of Alzchem Group AG for their direction of the company. All items
on the agenda were resolved by a large majority as proposed by the management. Particularly noteworthy is the increase
in the dividend to EUR 1.20 per share (previous year: EUR 1.05), which was made possible by Alzchem's strong earnings
performance in the fiscal year 2023. The plenary session also approved the discharge of the Management Board and
Supervisory Board, the appointment of the auditor for the annual and consolidated financial statements for 2024 and the
sustainability report for 2024, the remuneration report, the authorization to acquire and use treasury shares as well
as an amendment to the articles of association.
Andreas Niedermaier, CEO of Alzchem Group AG: "The extraordinarily high level of approval from our shareholders for all
items on the agenda confirms the successful development and strategy of Alzchem. Our consistent transformation to
specialty chemicals has proven itself impressively in 2023 and enables us to allow our shareholders to participate in
Alzchem's success in the form of a significantly increased dividend. We also expect sustained profitable growth in the
coming years."
The detailed voting results for the individual items on the agenda of the Annual General Meeting can be downloaded from
the company website at https://www.alzchem.com/en/investor-relations/annual-general-meeting/.
About Alzchem
Alzchem is a globally active specialty chemicals company that is one of the market leaders in most of its fields of
activity. Alzchem benefits from the three very different global developments climate change, population growth and
longer life expectancy in a unique way. Alzchem products can offer attractive solutions for achieving the resulting
social goals in a multitude of different applications.
The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in
particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw
materials and creatine products can contribute to a healthy old age as life expectancy increases.
Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and
across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
Alzchem Group AG's broad product range includes dietary supplements, precursors for PCR tests and pharmaceutical raw
materials. These offerings are the company's response to global trends and developments. Alzchem is ideally positioned
in this respect and considers itself well prepared for an environmental future and global developments.
The company employs around 1,690 people at four production sites in Germany and a plant in Sweden, as well as three
sales companies in the USA, China and England. Alzchem generated Group sales of EUR 540.6 million and EBITDA of EUR
81.4 million in 2023.
2024-05-07 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com  
Language:     English 
Company:      Alzchem Group AG 

Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany

Phone:        +498621862888 
Fax:          +49862186502888 
E-mail:       ir@alzchem.com 
Internet:     www.alzchem.com 
ISIN:         DE000A2YNT30 
WKN:          A2YNT3 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart 
EQS News ID:  1897891 

End of News EQS News Service
===
1897891 2024-05-07 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1897891&application_name=news

END) Dow Jones Newswires

May 07, 2024 10:22 ET (14:22 GMT)